Why HIV virions have low numbers of envelope spikes: implications for vaccine development
- PMID: 25101974
- PMCID: PMC4125284
- DOI: 10.1371/journal.ppat.1004254
Why HIV virions have low numbers of envelope spikes: implications for vaccine development
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures


Similar articles
-
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design.Annu Rev Immunol. 2016 May 20;34:635-59. doi: 10.1146/annurev-immunol-041015-055515. Annu Rev Immunol. 2016. PMID: 27168247 Free PMC article. Review.
-
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level.Nat Med. 2010 Sep;16(9):995-7. doi: 10.1038/nm.2203. Epub 2010 Aug 29. Nat Med. 2010. PMID: 20802498
-
The search for effective HIV vaccines.N Engl J Med. 2005 Aug 25;353(8):753-7. doi: 10.1056/NEJMp058146. N Engl J Med. 2005. PMID: 16120854 No abstract available.
-
The RV144 Thai HIV vaccine trial.Hum Vaccin. 2010 Feb;6(2):159. Epub 2010 Feb 18. Hum Vaccin. 2010. PMID: 20431337 No abstract available.
-
Role of neutralizing antibodies in HIV infection.AIDS. 2003;17 Suppl 4:S67-71. doi: 10.1097/00002030-200317004-00008. AIDS. 2003. PMID: 15080182 Review. No abstract available.
Cited by
-
Nanoparticle Vaccines for Inducing HIV-1 Neutralizing Antibodies.Vaccines (Basel). 2019 Jul 29;7(3):76. doi: 10.3390/vaccines7030076. Vaccines (Basel). 2019. PMID: 31362378 Free PMC article. Review.
-
A novel anti-HIV-1 bispecific bNAb-lectin fusion protein engineered in a plant-based transient expression system.Plant Biotechnol J. 2019 Aug;17(8):1646-1656. doi: 10.1111/pbi.13090. Epub 2019 Mar 12. Plant Biotechnol J. 2019. PMID: 30729651 Free PMC article.
-
A proof-of-concept study for the design of a VLP-based combinatorial HPV and placental malaria vaccine.Sci Rep. 2019 Mar 27;9(1):5260. doi: 10.1038/s41598-019-41522-5. Sci Rep. 2019. PMID: 30918267 Free PMC article.
-
Optimal Expression, Function, and Immunogenicity of an HIV-1 Vaccine Derived from the Approved Ebola Vaccine, rVSV-ZEBOV.Vaccines (Basel). 2023 May 12;11(5):977. doi: 10.3390/vaccines11050977. Vaccines (Basel). 2023. PMID: 37243081 Free PMC article.
-
Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccine.Future Virol. 2019 Feb;14(2):51-54. doi: 10.2217/fvl-2018-0174. Epub 2019 Jan 10. Future Virol. 2019. PMID: 30815025 Free PMC article. No abstract available.
References
-
- Zhu P, Liu J, Bess J Jr, Chertova E, Lifson JD, et al. (2006) Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441: 847–852. - PubMed
-
- Hangartner L, Zinkernagel RM, Hengartner H (2006) Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol 6: 231–243. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical